Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.
提供了Kappa阿片受体拮抗剂,可在功能性结合测定中显著改善对Kappa阿片受体的结合,并将这些拮抗剂用于治疗因结合Kappa阿片受体而改善的疾病状态,例如
海洛因或
可卡因成瘾。